Fundraising Fox
NVision
7 known investors
Find your way into NVision
Sign up to see every warm intro you have to NVision
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NVision team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
nVision Quantum develops POLARIS, an on-site system that uses parahydrogen-induced hyperpolarization to amplify metabolic imaging agents for real-time, non-invasive metabolic imaging with standard MRI. It targets research labs and clinical imaging workflows in the medical imaging field, offering automated dose production with ready-to-use kits.
Investors · 7
How we know: Matterwave Ventures's portfolio page · thequantuminsider.com · Not right? Tell us
How we know: Playground Global's portfolio page · funding news · thequantuminsider.com · Not right? Tell us
How we know: thequantuminsider.com · Not right? Tell us
How we know: funding news · thequantuminsider.com · Not right? Tell us
How we know: funding news · thequantuminsider.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$55M disclosed across 1 of 2 rounds · 2026
- $55MSeries BMay 2026 · 4 sources
Abbott (lead), b2ventures, CDP Venture Capital, Entrée Capital, European Investment Bank, Matterwave, Playground Global
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does NVision do?
- nVision Quantum develops POLARIS, an on-site system that uses parahydrogen-induced hyperpolarization to amplify metabolic imaging agents for real-time, non-invasive metabolic imaging with standard MRI. It targets research labs and clinical imaging workflows in the medical imaging field, offering automated dose production with ready-to-use kits.
- Who are NVision's investors?
- NVision's investors include Matterwave Ventures, Playground Global, Abbott, CDP Venture Capital, Entrée Capital, European Investment Bank.
- How much funding has NVision raised?
- NVision has disclosed $55M raised across 1 of its 2 known rounds.